TCI Wealth Advisors, Inc. - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 187 filers reported holding TRILLIUM THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.3%.

Quarter-by-quarter ownership
TCI Wealth Advisors, Inc. ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$9,000
+200.0%
508
+69.3%
0.00%0.0%
Q2 2021$3,000
-62.5%
300
-57.1%
0.00%
-66.7%
Q1 2021$8,000
-20.0%
7000.0%0.00%
-25.0%
Q4 2020$10,000
+42.9%
700
+40.0%
0.00%
+33.3%
Q3 2020$7,000
+133.3%
500
+25.0%
0.00%
+200.0%
Q2 2020$3,000
+50.0%
400
-33.3%
0.00%0.0%
Q1 2020$2,0006000.00%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders